U.S. Markets close in 4 hrs 18 mins
  • S&P 500

    4,513.36
    +26.90 (+0.60%)
     
  • Dow 30

    35,417.99
    +159.38 (+0.45%)
     
  • Nasdaq

    15,110.41
    +88.60 (+0.59%)
     
  • Russell 2000

    2,275.35
    +7.51 (+0.33%)
     
  • Gold

    1,771.20
    +5.50 (+0.31%)
     
  • EUR/USD

    1.1637
    +0.0019 (+0.1629%)
     
  • 10-Yr Bond

    1.6220
    +0.0380 (+2.40%)
     
  • Vix

    15.93
    -0.38 (-2.33%)
     
  • GBP/USD

    1.3802
    +0.0075 (+0.5438%)
     
  • USD/JPY

    114.2670
    -0.0450 (-0.0394%)
     
  • BTC-USD

    62,624.32
    +772.55 (+1.25%)
     
  • CMC Crypto 200

    1,456.81
    -6.55 (-0.45%)
     
  • FTSE 100

    7,222.57
    +18.74 (+0.26%)
     
  • Nikkei 225

    29,215.52
    +190.06 (+0.65%)
     

LOGC & PAYS INVESTOR NOTIFICATION: Bronstein, Gewirtz & Grossman LLC Updates Investors of Class Actions and Encourages Investors to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / April 22, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

LogicBio Therapeutics, Inc. (LOGC)

Class Period: December 3, 2018 - February 10, 2020

Deadline: May 18, 2020
For more info: www.bgandg.com/logc

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) LogicBio Therapeutics, Inc.'s behind-schedule and rushed Investigational New Drug ("IND") submission of LB-001 did not answer certain pertinent clinical and nonclinical questions; (2) as a result, the U.S. Food and Drug Administration was likely to hold or deny the IND submission of LB-001 for treatment of methylmalonic acidemia (MMA); and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Paysign, Inc. (PAYS)

Class Period: March 12, 2019 - March 15, 2020

Deadline: May 18, 2020
For more info: www.bgandg.com/pays

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) Paysign's internal control over financial reporting was not effective; (2) Paysign's information technology general controls were not effective; and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/585776/LOGC-PAYS-INVESTOR-NOTIFICATION-Bronstein-Gewirtz-Grossman-LLC-Updates-Investors-of-Class-Actions-and-Encourages-Investors-to-Contact-the-Firm